Thermo Fisher Scientific

Evidence of pricing power shows up in resilient gross margins around 39 to 42 percent and stable GAAP operating margins near the high‑teens over multiple quarters, despite a mixed funding backdrop.

Consumables and services dominate the mix, providing latitude for periodic price actions, particularly in GMP‑qualified reagents and critical lab supplies. That said, practitioner feedback highlights pushback on distributor pricing and service costs, which can limit list‑price increases in more commoditized categories.

Score reflects strong but not absolute pricing power.